|
1
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar
|
|
2
|
Chen L, Magliano DJ and Zimmet PZ: The
worldwide epidemiology of type 2 diabetes mellitus-present and
future perspectives. Nat Rev Endocrinol. 8:228–236. 2012.
View Article : Google Scholar
|
|
3
|
van Dieren S: Management of type 2
diabetes mellitus and prediction of cardiovascular complications.
Thesis. Utrecht University; ISBN: 978-94-6203-340-52013
|
|
4
|
Tabit CE, Chung WB, Hamburg NM and Vita
JA: Endothelial dysfunction in diabetes mellitus: Molecular
mechanisms and clinical implications. Rev Endocr Metab Disord.
11:61–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Donath MY and Shoelson SE: Type 2 diabetes
as an inflammatory disease. Nat Rev Immunol. 11:98–107. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pedicino D, Liuzzo G, Trotta F, Giglio AF,
Giubilato S, Martini F, Zaccardi F, Scavone G, Previtero M, Massaro
G, et al: Adaptive immunity, inflammation, and cardiovascular
complications in type 1 and type 2 diabetes mellitus. J Diabetes
Res. 2013:1842582013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sivitz WI and Yorek MA: Mitochondrial
dysfunction in diabetes: From molecular mechanisms to functional
significance and therapeutic opportunities. Antioxid Redox Signal.
12:537–577. 2010. View Article : Google Scholar :
|
|
9
|
Zhong Q and Kowluru RA: Epigenetic changes
in mitochondrial superoxide dismutase in the retina and the
development of diabetic retinopathy. Diabetes. 60:1304–1313. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Dieren S, Beulens JW, van der Schouw
YT, Grobbee DE and Neal B: The global burden of diabetes and its
complications: An emerging pandemic. Eur J Cardiovasc Prev Rehabil.
17(Suppl 1): S3–S8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sladek R, Rocheleau G, Rung J, Dina C,
Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, et al:
A genome-wide association study identifies novel risk loci for type
2 diabetes. Nature. 445:881–885. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeggini E, Weedon MN, Lindgren CM,
Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW,
Freathy RM, et al: Replication of genome-wide association signals
in UK samples reveals risk loci for type 2 diabetes. Science.
316:1336–1341. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barrett JC, Clayton DG, Concannon P,
Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J,
Nierras C, et al: Genome-wide association study and meta-analysis
find that over 40 loci affect risk of type 1 diabetes. Nat Genet.
41:703–707. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Voight BF, Scott LJ, Steinthorsdottir V,
Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS,
Thorleifsson G, et al: Twelve type 2 diabetes susceptibility loci
identified through large-scale association analysis. Nat Genet.
42:579–589. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pezzolesi MG, Poznik GD, Mychaleckyj JC,
Paterson AD, Barati MT, Klein JB, Ng DP, Placha G, Canani LH,
Bochenski J, et al: Genome-wide association scan for diabetic
nephropathy susceptibility genes in type 1 diabetes. Diabetes.
58:1403–1410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pirola L, Balcerczyk A, Okabe J and
El-Osta A: Epigenetic phenomena linked to diabetic complications.
Nat Rev Endocrinol. 6:665–675. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reddy MA and Natarajan R: Epigenetic
mechanisms in diabetic vascular complications. Cardiovasc Res.
90:421–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
von Mering C, Huynen M, Jaeggi D, Schmidt
S, Bork P and Snel B: STRING: A database of predicted functional
associations between proteins. Nucleic Acids Res. 31:258–261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Watts DJ and Strogatz SH: Collective
dynamics of 'small-world' networks. Nature. 393:440–442. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rende D, Baysal N and Kirdar B: Complex
disease interventions from a network model for type 2 diabetes.
PloS One. 8:e658542013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sengupta U, Ukil S, Dimitrova N and
Agrawal S: Expression-based network biology identifies alteration
in key regulatory pathways of type 2 diabetes and associated
risk/complications. PloS One. 4:e81002009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hopkins AL: Network pharmacology: The next
paradigm in drug discovery. Nat Chem Biol. 4:682–690. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee JW and Salimi-Moosavi H: Bioanalysis
of target biomarker and PK/PD relevancy during the development of
biotherapeutics. Bioanalysis. 4:2513–2523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Z, Cort L, Eberwine R, Herrmann T,
Leif JH, Greiner DL, Yahalom B, Blankenhorn EP and Mordes JP:
Prevention of type 1 diabetes in the rat with an allele-specific
anti-T-cell receptor antibody: Vβ13 as a therapeutic target and
biomarker. Diabetes. 61:1160–1168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang IM, Stone DJ, Nickle D, Loboda A,
Puig O and Roberts C: Systems biology approach for new target and
biomarker identification. Curr Top Microbiol Immunol. 363:169–199.
2013.
|
|
26
|
Wang Z and Wang Y: Navigating personalized
medicine dependent on modular flexibility. Trends Mol Med.
19:393–395. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Santana-Codina N, Carretero R,
Sanz-Pamplona R, Cabrera T, Guney E, Oliva B, Clezardin P, Olarte
OE, Loza-Alvarez P, Méndez-Lucas A, et al: A transcriptome-proteome
integrated network identifies endoplasmic reticulum thiol
oxidoreductase (ERp57) as a hub that mediates bone metastasis. Mol
Cell Proteomics. 12:2111–2125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo T, Wu S, Shen X and Li L: Network
cluster analysis of protein-protein interaction network identified
biomarker for early onset colorectal cancer. Mol Biol Rep.
40:6561–6568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou Y, Xu J, Liu Y, Li J, Chang C and Xu
C: Rat hepatocytes weighted gene co-expression network analysis
identifies specific modules and hub genes related to liver
regeneration after partial hepatectomy. PloS One. 9:e948682014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mahdi R, Madduri AS, Wang G,
Strulovici-Barel Y, Salit J, Hackett NR, Crystal RG and Mezey JG:
Empirical Bayes conditional independence graphs for regulatory
network recovery. Bioinformatics. 28:2029–2036. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang D, Han G, Feng X, Sun J, Duan Y and
Lei H: Concerted perturbation observed in a hub network in
Alzheimer's disease. PloS One. 7:e404982012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stehouwer CD, Lambert J, Donker AJ and van
Hinsbergh VW: Endothelial dysfunction and pathogenesis of diabetic
angiopathy. Cardiovasc Res. 34:55–68. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu L, Kanasaki K, Kitada M and Koya D:
Diabetic angiopathy and angiogenic defects. Fibrogenesis Tissue
Repair. 5:132012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kowluru RA, Santos JM and Mishra M:
Epigenetic modifications and diabetic retinopathy. Biomed Res Int.
2013:6352842013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wirostko B, Wong TY and Simó R: Vascular
endothelial growth factor and diabetic complications. Prog Retin
Eye Res. 27:608–621. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alghadyan AA: Diabetic retinopathy-An
update. Saudi J Ophthalmol. 25:99–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sivaskandarajah GA, Jeansson M, Maezawa Y,
Eremina V, Baelde HJ and Quaggin SE: Vegfa protects the glomerular
microvasculature in diabetes. Diabetes. 61:2958–2966. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Saltiel AR and Kahn CR: Insulin signalling
and the regulation of glucose and lipid metabolism. Nature.
414:799–806. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rains JL and Jain SK: Oxidative stress,
insulin signaling, and diabetes. Free Radic Biol Med. 50:567–575.
2011. View Article : Google Scholar
|
|
40
|
Kanaya AM, Wassel Fyr C, Vittinghoff E,
Harris TB, Park SW, Goodpaster BH, Tylavsky F and Cummings SR:
Adipocytokines and incident diabetes mellitus in older adults: The
independent effect of plasminogen activator inhibitor 1. Arch
Intern Med. 166:350–356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rasouli N and Kern PA: Adipocytokines and
the metabolic complications of obesity. J Clin Endocrinol Metab.
93(11 Suppl 1): S64–S73. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Beckman JA, Creager MA and Libby P:
Diabetes and atherosclerosis: Epidemiology, pathophysiology, and
management. JAMA. 287:2570–2581. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vigneri P, Frasca F, Sciacca L, Pandini G
and Vigneri R: Diabetes and cancer. Endocr Relat Cancer.
16:1103–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Giovannucci E, Harlan DM, Archer MC,
Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG and
Yee D: Diabetes and cancer: A consensus report. CA Cancer J Clin.
60:207–221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wolf I, Sadetzki S, Catane R, Karasik A
and Kaufman B: Diabetes mellitus and breast cancer. Lancet Oncol.
6:103–111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mandrup-Poulsen T: Apoptotic signal
transduction pathways in diabetes. Biochem Pharmacol. 66:1433–1440.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Allen DA, Yaqoob MM and Harwood SM:
Mechanisms of high glucose-induced apoptosis and its relationship
to diabetic complications. J Nutr Biochem. 16:705–713. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Barber AJ, Gardner TW and Abcouwer SF: The
significance of vascular and neural apoptosis to the pathology of
diabetic retinopathy. Invest Ophthalmol Vis Sci. 52:1156–1163.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bhatt MP, Lim YC, Kim YM and Ha KS:
C-peptide activates AMPKα and prevents ROS-mediated mitochondrial
fission and endothelial apoptosis in diabetes. Diabetes.
62:3851–3862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Vincent AM, Callaghan BC, Smith AL and
Feldman EL: Diabetic neuropathy: Cellular mechanisms as therapeutic
targets. Nat Rev Neurol. 7:573–583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Navaratna D, Guo SZ, Hayakawa K, Wang X,
Gerhardinger C and Lo EH: Decreased cerebrovascular brain-derived
neurotrophic factor-mediated neuroprotection in the diabetic brain.
Diabetes. 60:1789–1796. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang YY, Li HX, Chen YY, Fang H, Yu YN,
Liu J, Jing ZW, Wang Z and Wang YY: Convergent and divergent
pathways decoding hierarchical additive mechanisms in treating
cerebral ischemia-reperfusion injury. CNS Neurosci Ther.
20:253–263. 2014. View Article : Google Scholar
|
